MeSH term
Frequency | Condition_Probility | Animals | 7 | 0.0 |
Binding Sites | 4 | 0.0 |
Catalysis | 2 | 0.0 |
Humans | 10 | 0.0 |
Models, Molecular | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Acetylation | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 7 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 2 | 0.0 |
Animals, Genetically Modified | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Ligands | 2 | 0.0 |
Rats | 3 | 0.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Angiotensin II/*metabolism | 3 | 6.0 |
CHO Cells | 3 | 0.0 |
COS Cells | 3 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Hamsters | 3 | 0.0 |
Receptor, Angiotensin, Type 1 | 2 | 1.0 |
Receptors, Angiotensin/genetics/*metabolism | 2 | 50.0 |
Base Sequence | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Binding, Competitive | 2 | 0.0 |
